UNIVERSITY OF MASSACHUSETTS

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 27260
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 18135
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 98110
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 9129
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 8847
 
 
 
C07K PEPTIDES 7663
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 68172
 
 
 
C08F MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 4085
 
 
 
C08G MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 3882
 
 
 
C07D HETEROCYCLIC COMPOUNDS 37125

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0055,777 Hydrogel Beads With Self-Regulating Microclimate pH PropertiesAug 30, 17Mar 01, 18[A61K, A23L, B01J]
2018/0042,991 RECOMBINANT GLUT1 ADENO-ASSOCIATED VIRAL VECTOR CONSTRUCTS AND RELATED METHODS FOR RESTORING GLUT1 EXPRESSIONMar 10, 16Feb 15, 18[A61K, C12N, C07K]
2018/0042,998 TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPYMar 07, 16Feb 15, 18[A61K, C12Q, C12N, G01N]
2018/0044,635 SURFACE-MODIFIED MACROPHAGES FOR CELL-BASED DELIVERYAug 10, 17Feb 15, 18[C12N, A61B]
2018/0040,955 PLANAR ULTRAWIDEBAND MODULAR ANTENNA ARRAY HAVING IMPROVED BANDWIDTHFeb 25, 16Feb 08, 18[H01Q]
2018/0022,831 NANOPARTICLE-PROTEIN COMPLEX FOR INTRACELLULAR PROTEIN DELIVERYJan 29, 16Jan 25, 18[C12N, C07K]
2018/0025,074 Analogy FinderSep 27, 17Jan 25, 18[G06F]
2018/0014,819 MICROBIOPSY DEVICEJul 29, 16Jan 18, 18[A61B]
2018/0016,445 CROSSLINKED PHENOLIC COMPOUND, METHOD OF FORMING, AND POLYMER COMPOSITION CONTAINING THE SAMEJul 12, 17Jan 18, 18[C09K, C08G, C09D, D06M, C08L]
2017/0368,099 Cancer ImmunotherapyJan 22, 16Dec 28, 17[A61K, C12N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920353 Sensors and methods for capture, killing, and release of bacteriaSep 30, 14Mar 20, 18[C12Q, G01N, A61L]
9914924 Methods and compositions for treating neurological diseaseJan 05, 15Mar 13, 18[A61K, C12Q, C12N]
9914936 Nucleic acid silencing sequencesMar 18, 16Mar 13, 18[C07H, A61K, C12N]
9915647 Methods, compositions and kits for assaying mitochondrial functionMar 31, 16Mar 13, 18[C12Q, G01N, C07K]
9908871 Monomers and polymers for functional polycarbonates and poly(ester-carbonates) and PEG-co-polycarbonate hydrogelsJun 10, 16Mar 06, 18[C08G, C07D, C07C, A61L, C08L]
9896485 Nanopore sensors and uses thereofJul 22, 14Feb 20, 18[G01N, C40B, C07K]
9896683 Isolating circulating microRNA (miRNA)Jul 29, 15Feb 20, 18[C12Q, C12P, C12N]
9891231 Soluble MANF in pancreatic β-cell disordersJan 23, 13Feb 13, 18[A61K, C12N, G01N, C07K]
9885057 RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficienciesNov 25, 15Feb 06, 18[C07H, A61K, C12N]
9878296 Stabilizing liquid drops of arbitrary shape by the interfacial jamming of nanoparticlesOct 08, 14Jan 30, 18[A61K, B82Y, B01F]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0369,882 FULLY STABILIZED ASYMMETRIC SIRNAAbandonedAug 30, 17Dec 28, 17[C12N]
2017/0282,147 NANOSTRUCTURED APPARATUS AND METHODS FOR PRODUCING CARBON-CONTAINING MOLECULES AS A RENEWABLE ENERGY RESOURCEAbandonedJun 12, 17Oct 05, 17[C01B, B82Y, B01J]
2017/0193,339 Feature Type Spectrum TechniqueAbandonedMar 23, 17Jul 06, 17[G06K]
2017/0068,725 Analogy FinderAbandonedNov 18, 16Mar 09, 17[G06F]
2016/0184,449 PEPTIDE-AND AMINE-MODIFIED GLUCAN PARTICLES FOR DELIVERY OF THERAPEUTIC CARGOESAbandonedFeb 28, 14Jun 30, 16[A61K, C12N]
2016/0160,217 COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING MUSCULAR DYSTROPHYAbandonedFeb 12, 16Jun 09, 16[C12N]
2016/0152,694 ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND USES THEREOFAbandonedOct 29, 15Jun 02, 16[C07K]
2016/0045,612 FUNCTIONALIZED NANOPARTICLES FOR MEDICAL TREATMENTSAbandonedFeb 19, 14Feb 18, 16[A61K]
2016/0025,678 Electrochemical TongueAbandonedApr 03, 14Jan 28, 16[G01N]
2015/0366,074 Conductive Formulations For Use In Electrical, Electronic And RF ApplicationsAbandonedMar 31, 15Dec 17, 15[H05K]
2015/0323,514 SYSTEMS AND METHODS FOR FORECASTING BACTERIAL WATER QUALITYAbandonedApr 28, 15Nov 12, 15[G01N]
2015/0315,266 HUMAN ANTIBODIES AGAINST RABIES AND USES THEREOFAbandonedDec 02, 14Nov 05, 15[A61K, C07K]
2015/0313,881 Therapeutic Methods for Type I DiabetesAbandonedApr 29, 15Nov 05, 15[A61K]
2015/0202,212 METHODS FOR IDENTIFYING AGENTS FOR TREATING SMOOTH MUSCLE DISORDERS AND COMPOSITIONS THEREOFAbandonedJul 22, 13Jul 23, 15[A61K, G01N]
2015/0130,917 MINIATURE CONTACTLESS FINGERPRINTING DEVICEAbandonedNov 11, 14May 14, 15[H04N, G06K]
2015/0125,397 DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IMMUNE CELL RECEPTORS AND AUTOANTIGENSAbandonedOct 06, 14May 07, 15[A61K, G01N, C07K]
2015/0093,543 BLOOD COMPATIBLE SURFACESAbandonedSep 30, 14Apr 02, 15[A61L]
2015/0051,298 METHODS FOR PRODUCING OPTIMAL STABLE NANOEMULSIONS AND FORMULATIONS OBTAINED THEREFROMAbandonedAug 13, 14Feb 19, 15[A61K, A01N, A23L]
8957197 RNA sequence-specific mediators of RNA interferenceWithdrawnJan 18, 11Feb 17, 15[C07H]
2015/0015,509 METHOD AND SYSTEM OF OBTAINING AFFECTIVE STATE FROM TOUCH SCREEN DISPLAY INTERACTIONSAbandonedJul 08, 14Jan 15, 15[G06N, G06F]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.